399 related articles for article (PubMed ID: 27634302)
21. Polycomb Repressive Complex 2 in Oncology.
Guo Y; Yu Y; Wang GG
Cancer Treat Res; 2023; 190():273-320. PubMed ID: 38113005
[TBL] [Abstract][Full Text] [Related]
22. EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer.
Wassef M; Luscan A; Aflaki S; Zielinski D; Jansen PWTC; Baymaz HI; Battistella A; Kersouani C; Servant N; Wallace MR; Romero P; Kosmider O; Just PA; Hivelin M; Jacques S; Vincent-Salomon A; Vermeulen M; Vidaud M; Pasmant E; Margueron R
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6075-6080. PubMed ID: 30867289
[TBL] [Abstract][Full Text] [Related]
23. The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis.
Ma X; Wang J; Wang J; Ma CX; Gao X; Patriub V; Sklar JL
Oncotarget; 2017 Jan; 8(3):4062-4078. PubMed ID: 27845897
[TBL] [Abstract][Full Text] [Related]
24. Polycomb Repressive Complex 2 Methylates Elongin A to Regulate Transcription.
Ardehali MB; Anselmo A; Cochrane JC; Kundu S; Sadreyev RI; Kingston RE
Mol Cell; 2017 Dec; 68(5):872-884.e6. PubMed ID: 29153392
[TBL] [Abstract][Full Text] [Related]
25. The histone H3K27 methylation mark regulates intestinal epithelial cell density-dependent proliferation and the inflammatory response.
Turgeon N; Blais M; Delabre JF; Asselin C
J Cell Biochem; 2013 May; 114(5):1203-15. PubMed ID: 23192652
[TBL] [Abstract][Full Text] [Related]
26. PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs.
Shan Y; Liang Z; Xing Q; Zhang T; Wang B; Tian S; Huang W; Zhang Y; Yao J; Zhu Y; Huang K; Liu Y; Wang X; Chen Q; Zhang J; Shang B; Li S; Shi X; Liao B; Zhang C; Lai K; Zhong X; Shu X; Wang J; Yao H; Chen J; Pei D; Pan G
Nat Commun; 2017 Sep; 8(1):672. PubMed ID: 28939884
[TBL] [Abstract][Full Text] [Related]
27. Regulation of CD11b transcription by decreasing PRC2 and increased acH4 level during ATRA-induced HL-60 differentiation.
Tang H; Chen F; Tan Q; Tan S; Liu L; Zhang F
Acta Biochim Biophys Sin (Shanghai); 2009 Jul; 41(7):588-93. PubMed ID: 19578722
[TBL] [Abstract][Full Text] [Related]
28. Dissecting the Roles of Polycomb Repressive Complex 2 Subunits in the Control of Skin Development.
Dauber KL; Perdigoto CN; Valdes VJ; Santoriello FJ; Cohen I; Ezhkova E
J Invest Dermatol; 2016 Aug; 136(8):1647-1655. PubMed ID: 26994968
[TBL] [Abstract][Full Text] [Related]
29. The polycomb repressive complex 2 is a potential target of SUMO modifications.
Riising EM; Boggio R; Chiocca S; Helin K; Pasini D
PLoS One; 2008 Jul; 3(7):e2704. PubMed ID: 18628979
[TBL] [Abstract][Full Text] [Related]
30. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.
Kirmizis A; Bartley SM; Kuzmichev A; Margueron R; Reinberg D; Green R; Farnham PJ
Genes Dev; 2004 Jul; 18(13):1592-605. PubMed ID: 15231737
[TBL] [Abstract][Full Text] [Related]
31. Cryptic RNA-binding by PRC2 components EZH2 and SUZ12.
Betancur JG; Tomari Y
RNA Biol; 2015; 12(9):959-65. PubMed ID: 26177152
[TBL] [Abstract][Full Text] [Related]
32. Polycomb repressive complex 2 is dispensable for maintenance of embryonic stem cell pluripotency.
Chamberlain SJ; Yee D; Magnuson T
Stem Cells; 2008 Jun; 26(6):1496-505. PubMed ID: 18403752
[TBL] [Abstract][Full Text] [Related]
33. Astemizole arrests the proliferation of cancer cells by disrupting the EZH2-EED interaction of polycomb repressive complex 2.
Kong X; Chen L; Jiao L; Jiang X; Lian F; Lu J; Zhu K; Du D; Liu J; Ding H; Zhang N; Shen J; Zheng M; Chen K; Liu X; Jiang H; Luo C
J Med Chem; 2014 Nov; 57(22):9512-21. PubMed ID: 25369470
[TBL] [Abstract][Full Text] [Related]
34. Mutations and deletions of PRC2 in prostate cancer.
Jain P; Di Croce L
Bioessays; 2016 May; 38(5):446-54. PubMed ID: 27000413
[TBL] [Abstract][Full Text] [Related]
35. Structural basis for PRC2 engagement with chromatin.
Glancy E; Ciferri C; Bracken AP
Curr Opin Struct Biol; 2021 Apr; 67():135-144. PubMed ID: 33232890
[TBL] [Abstract][Full Text] [Related]
36. Deletion of Polycomb Repressive Complex 2 From Mouse Intestine Causes Loss of Stem Cells.
Koppens MA; Bounova G; Gargiulo G; Tanger E; Janssen H; Cornelissen-Steijger P; Blom M; Song JY; Wessels LF; van Lohuizen M
Gastroenterology; 2016 Oct; 151(4):684-697.e12. PubMed ID: 27342214
[TBL] [Abstract][Full Text] [Related]
37. A model for transmission of the H3K27me3 epigenetic mark.
Hansen KH; Bracken AP; Pasini D; Dietrich N; Gehani SS; Monrad A; Rappsilber J; Lerdrup M; Helin K
Nat Cell Biol; 2008 Nov; 10(11):1291-300. PubMed ID: 18931660
[TBL] [Abstract][Full Text] [Related]
38. Roles of enhancer of zeste homolog 2: from skeletal muscle differentiation to rhabdomyosarcoma carcinogenesis.
Marchesi I; Giordano A; Bagella L
Cell Cycle; 2014; 13(4):516-27. PubMed ID: 24496329
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic regulation of embryonic ectoderm development in stem cell differentiation and transformation during ontogenesis.
Huang L; Li F; Ye L; Yu F; Wang C
Cell Prolif; 2023 Apr; 56(4):e13413. PubMed ID: 36727213
[TBL] [Abstract][Full Text] [Related]
40. PICOT binding to the polycomb group protein, EED, alters H3K27 methylation at the MYT1 PRC2 target gene.
Pandya P; Pasvolsky R; Babichev Y; Braiman A; Witte S; Altman A; Isakov N
Biochem Biophys Res Commun; 2019 Feb; 509(2):469-475. PubMed ID: 30595380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
